- $187.14m
- $510.87m
- $532.41m
- 80
- 97
- 88
- 99
Annual income statement for eHealth, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 583 | 538 | 405 | 453 | 532 |
| Cost of Revenue | |||||
| Gross Profit | 579 | 536 | 404 | 451 | 531 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 529 | 664 | 508 | 482 | 509 |
| Operating Profit | 53.3 | -126 | -103 | -29.1 | 23.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 54 | -125 | -106 | -30.6 | 19.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 45.5 | -104 | -88.7 | -28.2 | 10.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 45.5 | -104 | -88.7 | -28.2 | 10.1 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 45.5 | -123 | -119 | -66.5 | -35 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.68 | -3.35 | -3.9 | -2.37 | -1.02 |